Survival from pancreatic neuroendocrine tumours improved with surgery

08 Oct 2018


Research, presented at the North American Neuroendocrine Tumor Society symposium, suggests that patients with a stage II-IV pancreatic neuroendocrine tumour will survive longer if they have surgery to remove their tumour. 

Medpage Today 


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story